Alemtuzumab pretreatment and tacrolimus monotherapy in living-donor liver and kidney transplantation
| Autor: | Ron Shapiro, Wallis Marsh, Henkie P. Tan, Amadeo Marcos, Amit Basu, Ngoc Thai, Kusum Tom |
|---|---|
| Rok vydání: | 2010 |
| Předmět: |
medicine.medical_specialty
medicine.diagnostic_test business.industry Health Policy Liver and kidney medicine.medical_treatment Urology General Medicine Liver transplantation Living donor Tacrolimus Surgery Transplantation surgical procedures operative medicine Alemtuzumab Pharmacology (medical) Laparoscopy Complication business medicine.drug |
| Zdroj: | Expert review of pharmacoeconomicsoutcomes research. 7(2) |
| ISSN: | 1744-8379 |
| Popis: | We previously described the use of alemtuzumab as a pretreatment agent in 207 living-donor renal transplants, a trial that represented the largest series to date of live-donor renal and liver transplant recipients undergoing alemtuzumab pretreatment, and confirmed the short-term safety, efficacy and cost–effectiveness of this approach. This paper examines the use of the immunosuppressive combination of alemtuzumab and tacrolimus monotherapy in 47 patients with right-lobe adult living-donor liver transplantation. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|